Associated factors of osteoporosis and vascular calcification in patients awaiting kidney transplantation
- PMID: 37093441
- PMCID: PMC10611617
- DOI: 10.1007/s11255-023-03606-0
Associated factors of osteoporosis and vascular calcification in patients awaiting kidney transplantation
Abstract
Introduction: Pretransplant osteoporosis and vascular calcification probably increase the risk of fractures and cardiovascular events after kidney transplantation. In the present study, we investigated the related risk factors of osteoporosis and vascular calcification among end-stage renal disease (ESRD) patients awaiting kidney transplantation.
Methods: A total of 221 ESRD patients (age, 43.4 ± 14.3 years; 125 males and 96 females; median dialysis duration, 61.0 m) awaiting kidney transplantation were enrolled in this cross-sectional study. Serum levels of bone turnover markers and intact parathyroid hormone (iPTH) were analyzed from fasting morning blood samples. Dual-energy X-ray absorptiometry was used to measure bone mineral density (BMD). Vascular calcification was evaluated by lateral abdominal radiography and plain radiographic films of the pelvis and hands.
Results: The osteoporosis prevalence was 27.6% in this cohort of kidney transplantation candidates, and the prevalence of vascular calcification was 51.1%. The related factors for osteoporosis and vascular calcification were similar and included older age, longer dialysis duration, parathyroid hyperplasia, and higher levels of iPTH and bone turnover markers. In the multivariable regression model, age and iPTH were independent risk predictors of both vascular calcification and osteoporosis. There were strong, positive correlations between iPTH and all bone turnover markers. The moderate and severe hyperparathyroidism (iPTH 600-1499 pg/ml and iPTH 1500 pg/ml) were related to reduced serum albumin and hemoglobin levels.
Conclusion: The involvement of high iPTH levels in vascular calcification, osteoporosis, and malnutrition indicated the need of treating hyperparathyroidism early in patients awaiting kidney transplantation. Prospective studies are needed to further examine the utility of bone turnover markers.
Keywords: Bone turnover markers; Osteoporosis; Secondary hyperparathyroidism; Vascular calcification.
© 2023. The Author(s).
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures
Similar articles
-
Bone turnover markers predict type of bone histomorphometry and bone mineral density in Asian chronic haemodialysis patients.Nephrology (Carlton). 2020 Feb;25(2):163-171. doi: 10.1111/nep.13593. Epub 2019 May 2. Nephrology (Carlton). 2020. PMID: 30980579
-
Are we overconcerned about secondary hyperparathyroidism and underestimating the more common secondary hypoparathyroidism in our dialysis patients?J Assoc Physicians India. 2012 Feb;60:102-5. J Assoc Physicians India. 2012. PMID: 22715556
-
Study of chronic kidney disease-mineral bone disorders in newly detected advanced renal failure patients: A Hospital-based cross-sectional study.Saudi J Kidney Dis Transpl. 2017 Jul-Aug;28(4):874-885. Saudi J Kidney Dis Transpl. 2017. PMID: 28748891
-
The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients.Biomed Res Int. 2017;2017:9035193. doi: 10.1155/2017/9035193. Epub 2017 Feb 14. Biomed Res Int. 2017. PMID: 28286773 Free PMC article. Review.
-
Atherosclerosis, vascular calcification and osteoporosis.Med Clin (Barc). 2025 Feb 28;164(4):e13-e20. doi: 10.1016/j.medcli.2024.07.004. Epub 2024 Nov 14. Med Clin (Barc). 2025. PMID: 39547901 Review. English, Spanish.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical